Arrhythmia, Heart Failure
Conditions
Brief summary
The Registry will evaluate how HRV Monitor diagnostics change after cardiac resynchronization therapy in patients with heart failure.
Interventions
DEVICECardiac Resynchronization Therapy
Sponsors
Boston Scientific Corporation
Study design
Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients receiving their first CRT-D * Patients who sign and date a Patient Informed Consent prior to device implant * Patients who are available and willing to attend follow-up visits at the study center in which they were enrolled
Exclusion criteria
* Patients who are anticipated to receive pacing modes other than DDD or VDD (i.e., chronic atrial fibrillation patients are excluded), or patients who are anticipated to receive adaptive rate therapy * Patients who are younger than 18 years of age * Patients whose life expectancy is less than six-months due to other medical conditions * Patients with or who are likely to receive a tricuspid or other valve prosthesis * Patients who are currently enrolled in another investigational study that would directly impact the treatment or outcome of the current study * Women who are pregnant
Outcome results
None listed